Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/21/17 → 8/20/19 |
A Phase 3, Double-Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX Passage Extension 34 (PE34) Process Administered Concomitantly with M-M-R II
- Rupp, Richard (PI)
Project: Other project